Książki na temat „Heart Effect of drugs on”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych książek naukowych na temat „Heart Effect of drugs on”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj książki z różnych dziedzin i twórz odpowiednie bibliografie.
H, Opie Lionel, red. Drugs for the heart. Wyd. 3. Philadelphia: W.B. Saunders Co., 1991.
Denis, Noble, i Earm Yung E, red. Ionic channels and effect of taurine on the heart. Boston: Kluwer Academic Publishers, 1993.
G, Reves J., i Hall Kenneth D, red. Common problems in cardiac anesthesia. Chicago: Year Book Medical Publishers, 1987.
R, Watson Ronald, i Myers Adam K, red. Alcohol and heart disease. London: Taylor & Francis, 2002.
Droogmans, Steven. Drug-induced valvular heart disease. Hauppauge, N.Y: Nova Science Publishers, 2010.
I, Simpson Joseph, red. Anesthesia and the patient with co-existing heart disease. Boston: Little, Brown, 1993.
Gavin, Katherine T. Investigations of cardiovascular [alpha]-adrenoceptor function. Dublin: University College Dublin, 1997.
M, Muggia Franco, Green Michael D. 1949- i Speyer James L, red. Cancer treatment and the heart. Baltimore: Johns Hopkins University Press, 1992.
Myers, Adam K., i Ronald R. Watson. Alcohol and heart disease. London: Taylor & Francis, 2003.
International Symposium on the Organ Directed Toxicities of Anticancer Drugs (1st 1987 Burlington, Vt.). Organ directed toxicities of anticancer drugs: Proceedings of the First International Symposium on the Organ Directed Toxicities of Anticancer Drugs, Burlington, Vermont, USA, June 4-6, 1987. Boston: Nijhoff, 1988.
Haiat, Robert. Major clinical trials in cardiovascular therapeutics: 1995-2000 /$cRobert Haïat, Gérard Leroy ; reviewed by Anthony Saul ; preface by P. Théroux. Paris: Frison-Roche, 2001.
Ewer, Michael S. Cancer and the heart. Hamilton. ON: BC Decker Inc., 2007.
Kaski, Juan Carlos, i Baker Stuart. Drugs in cardiology: A comprehensive guide to cardiovascular pharmacotherapy. Oxford: Oxford University Press, 2010.
(Germany)), Freiburg Focus on Biomeasurement (9th 1995 Freiburg im Breisgau. Pharmacological evaluation of cardioprotective substances: Experimental induction and indicators of myocardial injury and myocardial protection. Buchenbach, Germany: Gesellschaft für Erfahrungstransfer in der Biomesstechnik e.V., 1996.
1927-, Iwata Heitarō, Lombardini J. Barry, Segawa Tomio 1927- i Japanese Research Society on Sulfur Amino Acids. Meeting, red. Taurine and the heart: Proceedings of the symposium annexed to the 10th Annual Meeting of the Japanese Research Society on Sulfur Amino Acids, Osaka, Japan, September 10, 1987. Boston: Kluwer Academic Publishers, 1989.
Brown, Hilary. Physiology and pharmacology of the heart. Oxford [England]: Blackwell Science, 1997.
Artman, Michael. Developmental changes in myocardial intropic responsiveness. Austin: R.G. Landes, 1994.
Turner, J. Rick. Integrated cardiac safety: Assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance. Hoboken, N.J: John Wiley & Sons, 2009.
1948-, Mann Stephan C., i Lazarus Arthur 1954-, red. Neuroleptic malignant syndrome and related conditions. Wyd. 2. Washington, DC: American Psychiatric Pub., 2003.
Ignarro, Louis J. No more heart disease: How nitric oxide can prevent--even reverse--heart attack and stroke. New York: St. Martin's Press, 2005.
Howder, Cynthia L. Cardiopulmonary pharmacology: A handbook for cardiopulmonary practitioners and other allied health personnel. Wyd. 2. Baltimore, MD: Williams & Wilkins, 1996.
Howder, Cynthia L. Cardiopulmonary pharmacology: A handbook for respiratory practitioners and other allied health personnel. Baltimore: Williams & Wilkins, 1992.
Khan, M. I. Gabriel. Heart attacks, hypertension, and heart drugs. Emmaus, Pa: Rodale Press, 1987.
H, Opie Lionel. Drugs for the heart. Wyd. 6. Philadelphia: W.B. Saunders, 2005.
Opie, Lionel H. Drugs for the heart. Wyd. 4. Philadelphia, PA: W.B. Saunders, 1995.
Hamer, John, red. Drugs for Heart Disease. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4899-3294-5.
H, Opie Lionel. Drugs for the heart. Wyd. 7. Philadelphia: Saunders / Elsevier, 2009.
H, Messerli Franz, red. The Heart and hypertension. New York, N.Y: Yorke Medical Books, 1987.
Friedman, David P. Drugs and the brain. Bethesda, Md: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, 1991.
Friedman, David P. Drugs and the brain. Bethesda, Md. (9000 Rockville Pike, Bethesda 20892): National Institutes of Health, The Clinical Center, 1993.
Tofler, Oswald B. The Heart of the social drinker. London: Lloyd-Luke ( Medical Books ) Ltd, 1985.
H, Opie Lionel, i Chatterjee Kanu, red. Drugs for the heart. Wyd. 4. Philadelphia: W.B. Saunders, 1995.
H, Opie Lionel, Chatterjee Kanu i Opie Lionel H, red. Drugs for the heart. Wyd. 2. Orlando: Grune & Stratton, 1987.
Jackson, Graham. Sex, The Heart and Erectile Dysfunction. Informa Healthcare, 2004.
(Editor), Joel Morganroth, i Ihor Gussak (Editor), red. Cardiac Safety of Noncardiac Drugs: Practical Guidelines for Clinical Research and Drug Development. Humana Press, 2004.
Joel, Morganroth, i Gussak Ihor, red. Cardiac safety of noncardiac drugs: Practical guidelines for clinical research and drug development. Totowa, N.J: Humana Press, 2005.
Joel, Morganroth, i Gussak Ihor, red. Cardiac safety of noncardiac drugs: Practical guidelines for clinical research and drug development. Totowa, N.J: Humana Press, 2005.
Gussak, Ihor, various i Joel Morganroth. Cardiac Safety of Noncardiac Drugs: Practical Guidelines for Clinical Research and Drug Development. Humana, 2010.
Drugs for the heart. Wyd. 4. Philadelphia: W.B. Saunders, 1997.
Gersh, Bernard J., i Opie Lionel H. Drugs for the Heart. Elsevier - Health Sciences Division, 2013.
Drugs for heart disease. Wyd. 2. London: Chapman and Hall, 1987.
1927-, Hamer John, red. Drugs for heart disease. Wyd. 2. London: Chapman and Hall, 1987.
John, Hamer, red. Drugs for heart disease. Wyd. 2. London: Chapman and Hall, 1987.
Hamer, John. Drugs for Heart Disease. Wyd. 2. Chapman & Hall, 1987.
Sidney, Atkinson, United States. Agency for Healthcare Research and Quality. i Southern California Evidence-Based Practice Center/RAND., red. Pharmacologic management of heart failure and left ventricular systolic dysfunction: Effect in female, black, and diabetic patients, and cost-effectiveness. Rockville, MD: U.S. Dept. of Health and Human Services, Public Health Service, Agency for Healthcare Research and Quality, 2003.
Rios, George. Heart Drugs and Their Side Effects. Phillips Pub Co, 1988.
G, Estafanous F., red. Anesthesia and the heart patient. Boston: Butterworths, 1989.
L, Catapano Alberico, i International Symposium on Drugs Affecting Lipid Metabolism, (11th : 1992 : Florence, Italy), red. Drugs affecting lipid metabolism. Dordrecht: Kluwer Academic Publishers, 1993.
Paoletti, Rodolfo, Alberico L. Catapano, Antonio M. Gotto Jr i Louis C. Smith. Drugs Affecting Lipid Metabolism. Springer, 2012.
Paoletti, Rodolfo, Alberico L. Catapano, Antonio M. Gotto Jr i Louis C. Smith. Drugs Affecting Lipid Metabolism. Springer, 2012.